Keryn is a postdoctoral associate in the Lek Lab. He started his our research group at the Yale School of Medicine, Department of Genetics in January Foundation During his time in the Broad Institute, he lead the exome/genome analysis of MYOSEQ (European cohort of >1000 LGMD patients) and SeqNMD (an international consortium of undiagnosed rare muscle diseases) which has resulted in novel disease gene discovery. Monkol has a strong passion for rare muscle disease research as a patient with Limb Girdle Muscular dystrophy (LGMD2G). He also coordinated the data processing and preliminary analysis of NIH Gabriella Miller Kids First (GMKF) cohorts sequenced or reprocessed at the Broad Institute.
As lead analyst, he oversaw the analysis strategy for all major CMG collaborations and organized monthly meetings to foster sharing of new methods and analysis amongst the rare disease community. He went on to lead the NIH funded Broad Center for Mendelian Genomics (CMG) analysis team. He was the lead author/analyst for the Exome Aggregation Consortium (ExAC) project that was published in Nature 2016. Before that, she was a Genetics Associate at Genzyme Genetics (now LabCorp) where she was responsible for coordinating genetic testing and analysis.Monkol did his post-doctoral training in Daniel MacArthur’s lab based at Massachusetts General Hospital, Harvard Medical School and the Broad Institute. Previously, she served in various roles for the Office of Technology Licensing at Stanford University, including licensing, managing special projects and leading the technical marketing team. Prior to joining the Jain Foundation in 2021, she established the technical marketing program for the Office of Technology Management at Washington University in St. Primiano has extensive experience in university technology transfer, helping to move promising inventions from the bench to the bedside.
She contributes to the strategic direction of the Jain Foundation and works with the Scientific Advisory Board to develop and supervise a portfolio of dysferlinopathy research projects and patient programs. degree in Biology from the Massachusetts Institute of Technology. degree in Human Genetics (Genetic Counseling Track) from VCU School of Medicine and her B.S.
0 kommentar(er)
